Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
Please provide your email address to receive an email when new articles are posted on . BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless ...
Carolina Cataract & Laser Center (CCLC) announced on April 29 that David Vroman, M.D., is the first physician in South ...
Please provide your email address to receive an email when new articles are posted on . In advanced cases that may normally require a corneal transplant, Beckman said cross-linking with scleral lenses ...
SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...
(MASS APPEAL) – If you’ve been diagnosed with Keratoconus then Corneal Cross Linking might get you back to better eyesight. Mass Appeal’s Patrick Berry joined Dr. John P. Frangie, MD to learn more.
Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Keratoconus is a disease that has a new treatment coming to the Northern Virginia area. After being tested in Europe over the ...
Watch 22News on even more platforms with the launch of our connected TV apps — in addition to watching via antenna, satellite, cable, or on WWLP.com and the WWLP News App. Inside Faneuil Hall in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results